Department of Urology, the Affiliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong, China.
Prostate. 2011 Sep;71(12):1276-86. doi: 10.1002/pros.21345. Epub 2011 Feb 9.
The androgen receptor (AR) is a ligand-dependent transcription factor that mediates androgenic hormone action in cells. We recently demonstrated the involvement of phosphoinositide 3-OH kinase (PI3K) p110beta in AR transactivation and gene expression. In this study, we determined the upstream signals that lead to PI3K/p110beta activation and AR transactivation after androgen stimulation.
Human prostate cancer LAPC-4 and 22Rv1 cell lines were used for the experiments. AR transactivation was assessed using an androgen responsive element-driven luciferase (ARE-LUC) assay. Cell proliferation was examined using BrdU incorporation and MTT assays. Target genes were silenced using small interfering RNA (siRNA) approach. Gene expression was evaluated at the mRNA level (real-time RT-PCR) and protein level (Western blot). PI3K kinase activities were measured using immunoprecipitation-based in vitro kinase assay. The AR-DNA-binding activity was determined using chromatin-immunoprecipitation (ChIP) assay.
First, at the cellular plasma membrane, disrupting the integrity of caveolae microdomain with methyl-β-cyclodextrin (M-β-CD) abolished androgen-induced AR transactivation and gene expression. Then, knocking down caveolae structural proteins caveolin-1 or -2 with the gene-specific siRNAs significantly reduced androgen-induced AR transactivation. Next, silencing Gα(s) and Gα(12) genes but not other G-proteins blocked androgen-induced AR transactivation and cell proliferation. Consistently, overexpression of Gα(s) or Gα(12) active mutants enhanced androgen-induced AR transactivation, of which Gα(s) active mutant sensitized the AR to castration-level of androgen (R1881). Most interestingly, knocking down Gα(s) but not Gα(12) subunit significantly suppressed androgen-stimulated PI3K p110beta activation. However, ChIP analysis revealed that both Gα(s) or Gα(12) subunits are involved in androgen-induced AR interaction with the AR target gene PSA promoter region.
These data suggest that caveolae-associated G-protein alpha subunits are involved in AR transactivation by modulating the activities of different PI3K isoforms.
雄激素受体(AR)是一种配体依赖性转录因子,可介导细胞中雄激素激素的作用。我们最近证明了磷酸肌醇 3-羟激酶(PI3K)p110β参与 AR 转激活和基因表达。在这项研究中,我们确定了导致雄激素刺激后 PI3K/p110β激活和 AR 转激活的上游信号。
使用人前列腺癌细胞系 LAPC-4 和 22Rv1 进行实验。使用雄激素反应元件驱动的荧光素酶(ARE-LUC)测定法评估 AR 转激活。通过 BrdU 掺入和 MTT 测定法检查细胞增殖。使用小干扰 RNA(siRNA)方法沉默靶基因。通过实时 RT-PCR 和 Western blot 评估基因表达。使用基于免疫沉淀的体外激酶测定法测量 PI3K 激酶活性。通过染色质免疫沉淀(ChIP)测定法测定 AR-DNA 结合活性。
首先,在细胞质膜上,用甲基-β-环糊精(M-β-CD)破坏 caveolae 微域的完整性可消除雄激素诱导的 AR 转激活和基因表达。然后,用基因特异性 siRNA 敲低 caveolae 结构蛋白 caveolin-1 或 -2 可显著降低雄激素诱导的 AR 转激活。接下来,沉默 Gα(s)和 Gα(12)基因,但不是其他 G 蛋白,可阻断雄激素诱导的 AR 转激活和细胞增殖。一致地,过表达 Gα(s)或 Gα(12)活性突变体增强了雄激素诱导的 AR 转激活,其中 Gα(s)活性突变体使 AR 对去势水平的雄激素(R1881)敏感。最有趣的是,敲低 Gα(s)但不是 Gα(12)亚基可显著抑制雄激素刺激的 PI3K p110β激活。然而,ChIP 分析表明,Gα(s)或 Gα(12)亚基都参与了雄激素诱导的 AR 与 AR 靶基因 PSA 启动子区域的相互作用。
这些数据表明,caveolae 相关 G 蛋白α亚基通过调节不同 PI3K 同工型的活性参与 AR 转激活。